COVAX must start talks with COVID-19 vaccine makers: Merkel

2/2

© Reuters. German Chancellor Merkel and FM Scholz hold news conference in Berlin

2/2

FRANKFURT (Reuters) – German Chancellor Angela Merkel has urged COVAX, an initiative set up to provide COVID-19 vaccines to poorer countries, to start talks immediately with producers.

“I am concerned that there are no negotiations,” Merkel told journalists on Sunday after the G20 summit, at which leaders of the 20 biggest economies vowed to spare no effort to supply COVID-19 drugs, tests and vaccines to the world affordably and fairly.

Merkel said that, unlike COVAX, the European Union and the United States were already advanced in their efforts to secure vaccine doses.

“The most important thing is that COVAX now negotiates with producers of potential vaccines with the money it has,” Merkel said.

Dozens of countries have signed up to the global vaccine plan known as COVAX, which was set up by the World Health Organization and the GAVI vaccine group to provide vaccine doses for countries that could not otherwise afford them.

It has so far raised $5 billion, including over 500 million euros ($600 million) from Germany.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Admin

Leave a Reply

Your email address will not be published. Required fields are marked *